封面
市場調查報告書
商品編碼
1477262

美容注射市場,依類型(肉毒桿菌、真皮填充劑、富血小板血漿療法、脫氧膽酸等)、依應用、依最終用戶、地理位置

Aesthetic Injectables Market, By Type (Botulinum Toxin, Dermal Fillers, Platelet-Rich Plasma Therapy, Deoxycholic Acid, and Others), By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年美容注射市場價值為90.1億美元,預計到2031年將達到197.6億美元,2024年至2031年的年複合成長率(CAGR)為11.9%。

報告範圍 報告詳情
基準年: 2023年 2024 年市場規模: 90.1 億美元
歷史數據: 2019年至2023年 預測期: 2024年至2031年
預測 2024 年至 2031 年複合年成長率: 11.90% 2031 年價值預測: 197.6 億美元
圖 1. 美容注射劑市場佔有率 (%)(依地區),2024 年
美容注射市場 - IMG1

過去幾年,美容注射劑市場一直在快速成長。美容注射劑是指用於增強臉部特徵和膚色的真皮填充劑和推注劑。美學意識不斷提高、社交媒體影響力、可支配收入增加的中產階級人口不斷成長以及新產品的可用性不斷增加等因素一直在推動對美容手術的需求。然而,對某些產品副作用的安全性擔憂可能會阻礙市場成長。總體而言,隨著先進的天然和可生物分解產品的推出,美容注射市場的未來前景一片光明。

市場動態:

全球美容注射市場是由人們對外表和年輕外表的意識日益增強所推動的。然而,高昂的治療成本和與某些產品相關的副作用風險是一種限制。大眾社群媒體的影響力增加了自我評價和對外表的需求,為市場參與者提供了推廣產品的機會。填充劑技術的進步促進了基於透明質酸、基於膠原蛋白和富含血小板的血漿注射劑的開發,與傳統注射劑相比,它們具有更持久的效果和更低的副作用。儘管如此,一些地區缺乏熟練的專業人員和較少的醫療旅遊構成了課題。

研究的主要特點:

  • 該報告對全球美容注射市場進行了深入分析,並提供了以 2023 年為基準年的預測期(2024-2031)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它闡明了不同區隔市場的潛在收入成長機會,並解釋了該市場有吸引力的投資主張矩陣。
  • 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
  • 它根據以下參數描述了全球美容注射劑市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
  • 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球美容注射劑市場報告迎合了該行業的各個利益相關者,包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 利害關係人可以透過用於分析全球美容注射市場的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與假設

  • 研究目標
  • 假設
  • 縮寫

第 2 章:市場範圍

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map (COM)

第 3 章:市場動態、法規與趨勢分析

  • 市場動態
    • 促進要素
    • 限制
    • 機會
  • 影響分析
  • 市場走向
  • 最近的發展
  • 收購和合作場景
  • 技術概覽
  • 監管場景
  • 定價分析
  • PEST分析

第 4 章:全球美容注射市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第 5 章:2019 - 2031 年全球美容注射市場(依類型)(十億美元)

  • 概述
  • 肉毒桿菌毒素
  • 真皮填充劑
  • 富血小板血漿 (PRP) 療法
  • 脫氧膽酸
  • 其他

第 6 章:全球美容注射市場,依應用分類,2019 - 2031 年(十億美元)

  • 概述
  • 唇部增強
  • 減少皺紋
  • 痤瘡疤痕治療
  • 顴骨提升術
  • 其他

第 7 章:全球美容注射市場,依最終用戶分類,2019 - 2031 年(十億美元)

  • 概述
  • 醫院
  • 皮膚科診所
  • 其他

第 8 章:2019 - 2031 年全球美容注射市場(依地區)(十億美元)

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東協
  • 澳洲
  • 韓國
  • 亞太地區其他地區
  • 中東
  • 海灣合作理事會
  • 以色列
  • 中東其他地區
  • 非洲
  • 北非
  • 中非
  • 南非

第 9 章:競爭格局

  • 公司簡介
    • AbbVie
    • Galderma
    • Merz Pharma
    • Teoxane Laboratories
    • Sinclair Pharma
    • Suneva Medical
    • Croma-Pharma GmbH
    • Luminera Derm
    • Johnson & Johnson
    • Revance Therapeutics
    • Hyaltech Ltd
    • Bioxis Pharmaceuticals
    • Prollenium Medical Technologies
    • SciVision Biotech Inc.
    • Bloomage BioTechnology Corporation Ltd.

第 10 章:分析師觀點

  • 命運之輪
  • 分析師觀點
  • 連貫的機會圖

第 11 章:參考文獻與研究方法

  • 參考
  • 研究方法論
簡介目錄
Product Code: CMI6819

The aesthetic injectables market is estimated to be valued at USD 9.01 Bn in 2024 and is expected to reach USD 19.76 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.9% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 9.01 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 11.90% 2031 Value Projection: US$ 19.76 Bn
Figure 1. Aesthetic Injectables Market Share (%), By Region, 2024
Aesthetic Injectables Market - IMG1

The aesthetic injectables market has been growing at a rapid pace over the past few years. Aesthetic injectables refer to dermal fillers and bolus injections used to enhance facial features and skin complexion. Factors, such as rising awareness about aesthetics, social media influence, growing middle-class population with higher disposable incomes, and increasing availability of new products, have been driving the demand for aesthetic procedures. However, safety concerns regarding the side effects of certain products could hamper the market growth. Overall, the future prospects for the aesthetic injectables market looks promising with the introduction of advanced natural and biodegradable products.

Market Dynamics:

The global aesthetic injectables market is driven by the growing consciousness about physical appearance and youthful looks. However, high treatment costs and risks of side effects associated with certain products act as a restraint. Mass social media influence have increased self-assessment and the need to look good, opening up opportunities for market players to promote their products. Advancements in filler technologies have led to the development of hyaluronic acid-based, collagen-based, and platelet-rich plasma injectables with longer lasting results and lower side effects over traditional injectables. Nonetheless, lack of skilled professionals and lesser medical tourism in some regions poses a challenge.

Key Features of the Study:

  • This report provides an in-depth analysis of the global aesthetic injectables market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global aesthetic injectables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes AbbVie, Galderma, Merz Pharma, Teoxane Laboratories, Sinclair Pharma, Suneva Medical, Croma-Pharma GmbH, Luminera Derm, Johnson & Johnson, Revance Therapeutics, Hyaltech Ltd, Bioxis Pharmaceuticals, Prollenium Medical Technologies, SciVision Biotech Inc., and Bloomage BioTechnology Corporation Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global aesthetic injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aesthetic injectables market.

Detailed Segmentation-

  • Type:
    • Botulinum Toxin
    • Dermal Fillers
    • Platelet-Rich Plasma (PRP) Therapy
    • Deoxycolic Acid
    • Others
  • Application:
    • Lip Enhancement
    • Wrinkle Reduction
    • Acne Scar Treatment
    • Cheekbone Augmentation
    • Others
  • End User:
    • Hospitals
    • Dermatology Clinics
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • AbbVie
    • Galderma
    • Merz Pharma
    • Teoxane Laboratories
    • Sinclair Pharma
    • Suneva Medical
    • Croma-Pharma GmbH
    • Luminera Derm
    • Johnson & Johnson
    • Revance Therapeutics
    • Hyaltech Ltd
    • Bioxis Pharmaceuticals
    • Prollenium Medical Technologies
    • SciVision Biotech Inc.
    • Bloomage BioTechnology Corporation Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Pricing Analysis
  • PEST Analysis

4. Global Aesthetic Injectables Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Aesthetic Injectables Market, By Type, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Botulinum Toxin
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Dermal Fillers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Platelet-Rich Plasma (PRP) Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Deoxycolic Acid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Aesthetic Injectables Market, By Application, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Lip Enhancement
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Wrinkle Reduction
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Acne Scar Treatment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Cheekbone Augmentation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Aesthetic Injectables Market, By End User, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Dermatology Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. Global Aesthetic Injectables Market, By Region, 2019 - 2031, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • AbbVie
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Galderma
    • Merz Pharma
    • Teoxane Laboratories
    • Sinclair Pharma
    • Suneva Medical
    • Croma-Pharma GmbH
    • Luminera Derm
    • Johnson & Johnson
    • Revance Therapeutics
    • Hyaltech Ltd
    • Bioxis Pharmaceuticals
    • Prollenium Medical Technologies
    • SciVision Biotech Inc.
    • Bloomage BioTechnology Corporation Ltd.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact